Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (101-110 of 408) with videos related to

Pageof 41
Sort By:
Endocrinology and Metabolism (Seoul, Korea)|July 4, 2020
Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and SulfonylureaYujin Shin, Ji Hye Moon, Ho Jun Chin, et al.
Diabetes, Obesity & Metabolism|July 14, 2018
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescentsDomenico Tricò, Andrea Natali, Andrea Mari, et al.
Journal of Clinical Medicine|August 26, 2018
Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 DiabetesMarta Seghieri, Eleni Rebelos, Andrea Mari, et al.
JCI Insight|December 20, 2024
Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetesEle Ferrannini, Simona Baldi, Maria Tiziana Scozzaro, et al.
Diabetes|December 13, 2017
Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo EvidenceEleonora Grespan, Toni Giorgino, Silva Arslanian, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 16, 2006
Thiazolidinediones improve beta-cell function in type 2 diabetic patientsAmalia Gastaldelli, Ele Ferrannini, Yoshinori Miyazaki, et al.
Cardiovascular Diabetology|April 29, 2023
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCEGiulia Ferrannini, Carol Pollock, Andrea Natali, et al.
Diabetes Care|July 17, 2015
Energy Balance After Sodium-Glucose Cotransporter 2 InhibitionGiulia Ferrannini, Thomas Hach, Susanne Crowe, et al.
Diabetes|November 25, 2004
Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cellsEleonora Santini, Poupak Fallahi, Silvia Martina Ferrari, et al.
Journal of the American Society of Nephrology : JASN|December 7, 2007
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney diseaseChristian A Schneider, Ele Ferrannini, Ralph Defronzo, et al.
Pageof 41

Showing results (101-110 of 408) with videos related to

Sort By:
Pageof 41
Endocrinology and Metabolism (Seoul, Korea)|July 4, 2020
Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and SulfonylureaYujin Shin, Ji Hye Moon, Ho Jun Chin, et al.
Diabetes, Obesity & Metabolism|July 14, 2018
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescentsDomenico Tricò, Andrea Natali, Andrea Mari, et al.
Journal of Clinical Medicine|August 26, 2018
Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 DiabetesMarta Seghieri, Eleni Rebelos, Andrea Mari, et al.
JCI Insight|December 20, 2024
Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetesEle Ferrannini, Simona Baldi, Maria Tiziana Scozzaro, et al.
Diabetes|December 13, 2017
Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo EvidenceEleonora Grespan, Toni Giorgino, Silva Arslanian, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 16, 2006
Thiazolidinediones improve beta-cell function in type 2 diabetic patientsAmalia Gastaldelli, Ele Ferrannini, Yoshinori Miyazaki, et al.
Cardiovascular Diabetology|April 29, 2023
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCEGiulia Ferrannini, Carol Pollock, Andrea Natali, et al.
Diabetes Care|July 17, 2015
Energy Balance After Sodium-Glucose Cotransporter 2 InhibitionGiulia Ferrannini, Thomas Hach, Susanne Crowe, et al.
Diabetes|November 25, 2004
Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cellsEleonora Santini, Poupak Fallahi, Silvia Martina Ferrari, et al.
Journal of the American Society of Nephrology : JASN|December 7, 2007
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney diseaseChristian A Schneider, Ele Ferrannini, Ralph Defronzo, et al.
Pageof 41